Journal of Medicinal Chemistry motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158, 227–233. (3) Moolenaar, W. H.; van Meeteren, L. A.; Giepmans, B. N. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004, 26, 870–881. (4) Kanda, H.; Newton, R.; Klein, R.; Morita, Y.; Gunn, M.; Rosen, S. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 2008, 9, 415–423. (5) van Meeteren, L.; Moolenaar, W. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 2007, 46, 145–160. (6) Tager, A.; LaCamera, P.; Shea, B.; Campanella, G.; Selman, M.; Zhao, Z.; Polosukhin, V.; Wain, J.; Karimi-Shah, B.; Kim, N.; Hart, W.; Pardo, A.; Blackwell, T.; Xu, Y.; Chun, J.; Luster, A. The lysophosphatidic acid receptor LPA1 links pulmonary ﬁbrosis to lung injury by mediating ﬁbroblast recruitment and vascular leak. Nat. Med. 2008, 14, 45–54. (7) Stefan, C.; Jansen, S.; Bollen, M. Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic. Signal 2006, 2, 361–370. (8) Nishimasu, H.; Okudaira, S.; Hama, K.; Mihara, E.; Dohmae, N.; Inoue, A.; Ishitani, R.; Takagi, J.; Aoki, J.; Nureki, O. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat. Struct. Mol. Biol. 2011, 18, 205–212. (9) Hausmann, J.; Kamtekar, S.; Christodoulou, E.; Day, J.; Wu, T.; Fulkerson, Z.; Albers, H.; van Meeteren, L.; Houben, A.; van Zeijl, L.; Jansen, S.; Andries, M.; Hall, T.; Pegg, L.; Benson, T.; Kasiem, M.; Harlos, K.; Kooi, C.; Smyth, S.; Ovaa, H.; Bollen, M.; Morris, A.; Moolenaar, W.; Perrakis, A. Structural basis of substrate discrimination and integrin binding by autotaxin. Nat. Struct. Mol. Biol. 2011, 18, 198–204. (10) Gijsbers, R.; Aoki, J.; Arai, H.; Bollen, M. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett. 2003, 538, 60–64. (11) Gijsbers, R.; Ceulemans, H.; Stalmans, W.; Bollen, M. Structur- al and catalytic similarities between nucleotide pyrophosphatases/ phosphodiesterases and alkaline phosphatases. J. Biol. Chem. 2001, 276, 1361–1368. (12) Zalatan, J.; Fenn, T.; Brunger, A.; Herschlag, D. Structural and functional comparisons of nucleotide pyrophosphatase/phosphodies- terase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry 2006, 45, 9788–9803. (13) Albers, H.; van Meeteren, L.; Egan, D.; van Tilburg, E.; Moolenaar, W.; Ovaa, H. Discovery and optimization of boronic acid based inhibitors of autotaxin. J. Med. Chem. 2010, 53, 4958–4967. (14) Albers, H. M.; Dong, A.; van Meeteren, L. A.; Egan, D. A.; Sunkara, M.; van Tilburg, E. W.; Schuurman, K.; van Tellingen, O.; Morris, A. J.; Smyth, S. S.; Moolenaar, W. H.; Ovaa, H. Boronic acid- based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 7257–7262. (15) Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457–2483. (16) Mizufune, H.; Nakamura, M.; Mitsudera, H. Process research on arylnaphthalene lignan aza-analogues: a new palladium-catalyzed benzannulation of [alpha],[beta]-bisbenzylidenesuccinic acid deriva- tives. Tetrahedron 2006, 62, 8539–8549. (17) Cui, P.; Tomsig, J.; McCalmont, W.; Lee, S.; Becker, C.; Lynch, K.; Macdonald, T. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 1634–1640. (18) Fischer, G.; Mutel, V.; Trube, G.; Malherbe, P.; Kew, J. N. C.; Mohacsi, E.; Heitz, M. P.; Kemp, J. A. Ro 25 6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit. characterization in vitro. J. Pharmacol. Exp. Therapeutics 1997, 283, 1285–1292. (19) Jain, A.; Purohit, C.; Verma, S.; Sankararamakrishnan, R. Close contacts between carbonyl oxygen atoms and aromatic centers in protein structures: π-π or lone-pair-π interactions? J. Phys. Chem. B 2007, 111, 8680–8683. (20) Friesner, R.; Banks, J.; Murphy, R.; Halgren, T.; Klicic, J.; Mainz, D.; Repasky, M.; Knoll, E.; Shelley, M.; Perry, J.; Shaw, D.; ARTICLE Francis, P.; Shenkin, P. Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J. Med. Chem. 2004, 47, 1739–1749. (21) Friesner, R.; Murphy, R.; Repasky, M.; Frye, L.; Greenwood, J.; Halgren, T.; Sanschagrin, P.; Mainz, D. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein- ligand complexes. J. Med. Chem. 2006, 49, 6177–6196. (22) Halgren, T.; Murphy, R.; Friesner, R.; Beard, H.; Frye, L.; Pollard, W. T.; Banks, J. Glide: a new approach for rapid, accurate docking and scoring. 2. enrichment factors in database screening. J. Med. Chem. 2004, 47, 1750–1759. (23) Tan, S.; Ang, K.; Fong, Y. (Z)- and (E)-5-Arylmethylenehy- dantoins: spectroscopic properties and conﬁguration assignment. J. Chem. Soc., Perkin Trans. 2 1986, 1941–1944. (24) Shelley, J.; Cholleti, A.; Frye, L.; Greenwood, J.; Timlin, M.; Uchimaya, M. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. J. Comput.-Aided Mol. Des. 2007, 21, 681–691. 4626 dx.doi.org/10.1021/jm200310q |J. Med. Chem. 2011, 54, 4619–4626